Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Blood Advances
|
April 21, 2021
Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis
Hyehyun Jeong, Hyungwoo Cho, Hyeyeong Kim, et al.
Life Science Alliance
|
May 22, 2026
Development of K-CORE: a web-based platform for integrated clinico-genomic analysis
Juyeon Hwang, Jae Woo Ahn, Jae Wook Lee, et al.
JMIR Mhealth and Uhealth
|
September 24, 2025
Impact of a 24-Week Mobile App-Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort Study
Eun-Gyeong Lee, Dong-Eun Lee, Jeongseon Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
October 2, 2025
COPS5 inhibition synergizes with the antitumor effect of trastuzumab by PTEN upregulation in HER2-amplified gastric cancer
Sung-Hyun Hwang, Ji-Won Kim, Haeseong Park, et al.
Cancer Research and Treatment
|
July 16, 2024
The Cancer Clinical Library Database (CCLD) from the Korea-Clinical Data Utilization Network for Research Excellence (K-CURE) Project
Sangwon Lee, Yeon Ho Choi, Hak Min Kim, et al.
JAMA Oncology
|
July 7, 2022
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial
Hee Kyung Ahn, Sung Hoon Sim, Koung Jin Suh, et al.
Epidemiology and Health
|
October 24, 2025
Data profile: cancer sample cohorts (stomach, breast, colorectal, and liver) in Korea
Daewoo Pak, Suk Yong Jang, Jin-Ha Yoon, et al.
BMC Cancer
|
May 9, 2024
Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09
Sun Young Kim, Jee Hyun Kim, Tae-Yong Kim, et al.
The International Journal of Biological Markers
|
June 8, 2018
Prognostic implications of hepatitis B virus infection in intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin
Heejung Chae, Hyungwoo Cho, Changhoon Yoo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 3, 2019
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker
Heejung Chae, Deokhoon Kim, Changhoon Yoo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Blood Advances
|
April 21, 2021
Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis
Hyehyun Jeong, Hyungwoo Cho, Hyeyeong Kim, et al.
Life Science Alliance
|
May 22, 2026
Development of K-CORE: a web-based platform for integrated clinico-genomic analysis
Juyeon Hwang, Jae Woo Ahn, Jae Wook Lee, et al.
JMIR Mhealth and Uhealth
|
September 24, 2025
Impact of a 24-Week Mobile App-Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort Study
Eun-Gyeong Lee, Dong-Eun Lee, Jeongseon Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
October 2, 2025
COPS5 inhibition synergizes with the antitumor effect of trastuzumab by PTEN upregulation in HER2-amplified gastric cancer
Sung-Hyun Hwang, Ji-Won Kim, Haeseong Park, et al.
Cancer Research and Treatment
|
July 16, 2024
The Cancer Clinical Library Database (CCLD) from the Korea-Clinical Data Utilization Network for Research Excellence (K-CURE) Project
Sangwon Lee, Yeon Ho Choi, Hak Min Kim, et al.
JAMA Oncology
|
July 7, 2022
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial
Hee Kyung Ahn, Sung Hoon Sim, Koung Jin Suh, et al.
Epidemiology and Health
|
October 24, 2025
Data profile: cancer sample cohorts (stomach, breast, colorectal, and liver) in Korea
Daewoo Pak, Suk Yong Jang, Jin-Ha Yoon, et al.
BMC Cancer
|
May 9, 2024
Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09
Sun Young Kim, Jee Hyun Kim, Tae-Yong Kim, et al.
The International Journal of Biological Markers
|
June 8, 2018
Prognostic implications of hepatitis B virus infection in intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin
Heejung Chae, Hyungwoo Cho, Changhoon Yoo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 3, 2019
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker
Heejung Chae, Deokhoon Kim, Changhoon Yoo, et al.
Page
of 5